tradingkey.logo

AngioDynamics Inc

ANGO
查看詳細走勢圖
13.100USD
-0.060-0.46%
收盤 12/26, 16:00美東報價延遲15分鐘
542.95M總市值
虧損本益比TTM

AngioDynamics Inc

13.100
-0.060-0.46%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.46%

5天

-2.02%

1月

+6.50%

6月

+33.95%

今年開始到現在

+43.01%

1年

+47.03%

查看詳細走勢圖

TradingKey AngioDynamics Inc股票評分

單位: USD 更新時間: 2025-12-26

操作建議

AngioDynamics Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名24/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價18.50。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

AngioDynamics Inc評分

相關信息

行業排名
24 / 207
全市場排名
99 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 4 分析師
買入
評級
18.500
目標均價
+39.52%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

AngioDynamics Inc亮點

亮點風險
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
估值低估
公司最新PE估值-16.75,處於3年歷史低位
機構減倉
最新機構持股40.19M股,環比減少0.03%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉3.91K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.36

AngioDynamics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

AngioDynamics Inc簡介

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
公司代碼ANGO
公司AngioDynamics Inc
CEOClemmer (James C)
網址https://www.angiodynamics.com/

常見問題

AngioDynamics Inc(ANGO)的當前股價是多少?

AngioDynamics Inc(ANGO)的當前股價是 13.100。

AngioDynamics Inc 的股票代碼是什麼?

AngioDynamics Inc的股票代碼是ANGO。

AngioDynamics Inc股票的52週最高點是多少?

AngioDynamics Inc股票的52週最高點是13.990。

AngioDynamics Inc股票的52週最低點是多少?

AngioDynamics Inc股票的52週最低點是8.270。

AngioDynamics Inc的市值是多少?

AngioDynamics Inc的市值是542.95M。

AngioDynamics Inc的淨利潤是多少?

AngioDynamics Inc的淨利潤為-33.99M。

現在AngioDynamics Inc(ANGO)的股票是買入、持有還是賣出?

根據分析師評級,AngioDynamics Inc(ANGO)的總體評級為買入,目標價格為18.500。

AngioDynamics Inc(ANGO)股票的每股收益(EPS TTM)是多少

AngioDynamics Inc(ANGO)股票的每股收益(EPS TTM)是-0.782。
KeyAI